Table I.
Preoperative patient demographics, disease severity, and comorbidity prevalence for cases and controls
Cases with CF (n=20) |
Matched controls (n=20) |
p-value | ||
---|---|---|---|---|
Demographics: | (mean ± SD) | [range] | (mean ± SD) | |
Age (yrs.) | 30.2 ± 12.3 | [18 – 58] | 30.3 ± 12.4 | 0.968 |
Follow-up (mos.) | 13.1 ± 7.9 | [4 – 27] | 14.0 ± 6.0 | 0.620 |
Gender | n (%) | n (%) | ||
Male | 10 (50.0) | 10 (50.0) | ||
Female | 10 (50.0 | 10 (50.0) | >0.999 | |
Race/ethnicity | ||||
White | 20 (100.0) | 20 (100.0) | >0.999 | |
CRS Cofactors: | ||||
Nasal polyposis | 12 (60.0) | 6 (30.0) | 0.057 | |
Septal deviation | 3 (15.0) | 8 (40.0) | 0.155 | |
History of prior sinus surgery | 11 (55.0) | 8 (40.0) | 0.342 | |
Comorbid conditions: | ||||
Asthma | 4 (20.0) | 6 (30.0) | 0.716 | |
Allergic rhinitis | 1 (5.0) | 9 (45.0) | 0.008 | |
Aspirin triad | 0 (0.0) | 3 (15.0) | 0.231 | |
Depression | 4 (20.0) | 4 (20.0) | >0.999 | |
Current smoking | 1 (5.0) | 3 (15.0) | 0.605 |
Patients with chronic rhinosinusitis (CRS) and cystic fibrosis (CF) were matched 1:1 with control patients and compared for demographic factors, CRS cofactors, and comorbidity prevalence. SD = standard deviation. p ≤ 0.05 was statistically significant.